A noninterventional, multicenter, prospective phase IV study of trabectedin in patients with advanced soft tissue sarcoma
Keywords: observational; phase IV; sarcoma; soft tissue sarcoma; trabectedin
Document Type: Research Article
Affiliations: 1: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Sarcoma Unit, Medical Oncology, Royal Marsden Hospital, London, UK 2: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Locomotive Apparatus Tumor Unit, Orthopedic Service, Coimbra University Medical Center, Coimbra, Portugal 3: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Sarcoma Unit, Interdisciplinary Tumor Center, Mannheim University Medical Center, University of Heidelberg, Germany 4: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Medical Oncology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain 5: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Medical Oncology, L'Institut Roi Albert II, Bruxelles, Belgium 6: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Clinical Division of Oncology, Medical University Vienna - General Hospital, Austria 7: Department of Oncology, Medical Oncology, CRO, National Cancer Institute (IRCCS), Aviano (PN), Italy, Centre Oscar Lambret, General Oncology, Lille, France
Publication date: 01 November 2017
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content